Optimal fluoroscopic viewing angles of right-sided heart structures in patients with tricuspid regurgitation based on multislice computed tomography Xiong T, Pighi M, Thériault-Lauzier P, Leipsic J, Spaziano M, Martucci G, Buithieu J, Mousavi N, Pilgrim T, Praz F, Windecker S, Chen M, Piazza N November 15, 2019 | 10.4244/EIJ-D-19-00618
Interventions for stroke Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale Susuri N, Obeid S, Ulmi M, Siontis G, Wahl A, Windecker S, Nietlispach F, Meier B, Praz F September 20, 2017 | 10.4244/EIJ-D-17-00061
Interventions for valvular disease Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantation Franzone A, O’Sullivan C, Stortecky S, Heg D, Lanz J, Vollenbroich R, Praz F, Piccolo R, Asami M, Roost E, Räber L, Valgimigli M, Windecker S, Pilgrim T April 7, 2017 | 10.4244/EIJ-D-16-00790
Interventions for valvular disease Bilateral, reversible coronary obstruction during aortic valve-in-valve implantation of a repositionable valve system Praz F, Moschovitis A, Stortecky S, Pilgrim T, Eberle B, Windecker S October 20, 2016 | 10.4244/EIJV12I9A194
Interventions for valvular disease Effect of resting heart rate on two-year clinical outcomes of high-risk patients with severe symptomatic aortic stenosis undergoing transcatheter aortic valve implantation O’Sullivan C, Spitzer E, Heg D, Praz F, Stortecky S, Huber C, Carrel T, Pilgrim T, Windecker S July 20, 2016 | 10.4244/EIJV12I4A83
Interventions for valvular disease Transcatheter aortic valve implantation with the NVT Allegra transcatheter heart valve system: first-in-human experience with a novel self-expanding transcatheter heart valve Wenaweser P, Stortecky S, Schütz T, Praz F, Gloekler S, Windecker S, Elsasser A May 16, 2016 | 10.4244/EIJV12I1A13
A propensity score-matched comparison between Cardia and Amplatzer PFO closure devices - insights from the SOLUTION registry (Swiss percutaneOus patent foramen ovale cLosUre in recurrent clinical events prevenTION) Puricel S, Arroyo D, Goy J-J, Praz F, Palhais N, Wahl A, Stauffer J-C, Togni M, Berger A, Meier B, Cook S June 19, 2015 | 10.4244/EIJY14M05_05
Assessment of low-flow, low-gradient, severe aortic stenosis: an invasive evaluation is required for decision making O’Sullivan C, Praz F, Stortecky S, Windecker S, Wenaweser P September 27, 2014 | 10.4244/EIJV10SUA9
Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device Bapat V, Buellesfeld L, Peterson MD, Hancock J, Reineke D, Buller C, Carrel T, Praz F, Rajani R, Fam N, Kim H, Redwood S, Young C, Munns C, Windecker S, Thomas M September 27, 2014 | 10.4244/EIJV10SUA18
Cerebral protection devices for transcatheter aortic valve implantation: is better the enemy of good? Praz F, Nietlispach F September 15, 2013 | 10.4244/EIJV9SSA26
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
JAA This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more December 3, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019